Literature DB >> 9649215

Cytokine-enhanced mixed lymphocyte reaction (MLR) in cord blood.

M Umemoto1, E Azuma, M Hirayama, M Nagai, S Hiratake, J Qi, T Kumamoto, M Kobayashi, Y Komada, M Sakurai.   

Abstract

Although in cord blood (CB) transplantation graft-versus-host disease (GVHD) is reported to be less severe, GVHD may occur even in patients with HLA-identical sibling donors. This result shows that HLA typing can not entirely predict GVHD. The standard MLR with CB cells was either normal or slightly reduced compared with adult peripheral blood (PB) cells. We used two manipulations to increase the responses of CB cells to allo-antigens. The first was to treat the stimulator cells with cytokines, and the second to amplify weak proliferative responses by adding exogenous cytokines to MLR cultures (modified MLR). The stimulator cells were treated with both interferon-gamma (IFN-gamma) and IL-4. The responder cells were treated with both IL-2 and tumour necrosis factor-alpha (TNF-alpha). It is still to be determined whether or not this cytokine-enhanced MLR could be a possible predictor of GVHD. However, using these cytokines, 90% of CB could recognize allo-antigens, even if the standard MLR was negative.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649215      PMCID: PMC1904986          DOI: 10.1046/j.1365-2249.1998.00607.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes.

Authors:  D T Harris; M J Schumacher; J Locascio; F J Besencon; G B Olson; D DeLuca; L Shenker; J Bard; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Two cytotoxic pathways of natural killer cells in human cord blood: implications in cord blood transplantation.

Authors:  M Umemoto; E Azuma; M Hirayama; M Nagai; S Hiratake; J Qi; T Kumamoto; Y Komada; M Sakurai
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 3.  Graft-versus-host disease.

Authors:  J L Ferrara; H J Deeg
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

4.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

Authors:  E Gluckman; H A Broxmeyer; A D Auerbach; H S Friedman; G W Douglas; A Devergie; H Esperou; D Thierry; G Socie; P Lehn
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

5.  The genetic basis for reactivity in human mixed lymphocyte culture. 1. Studies of HL-A typed siblings.

Authors:  S F Sorensen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

6.  Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group.

Authors:  Y Morishima; Y Morishita; M Tanimoto; R Ohno; H Saito; K Horibe; N Hamajima; K Naito; K Yamada; S Yokomaku
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment.

Authors:  J E Wagner; H E Broxmeyer; R L Byrd; B Zehnbauer; B Schmeckpeper; N Shah; C Griffin; P D Emanuel; K S Zuckerman; S Cooper
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

8.  A study of cytokine production in acute graft-vs-host disease.

Authors:  S R Smith; C Terminelli; L Kenworthy-Bott; D L Phillips
Journal:  Cell Immunol       Date:  1991-05       Impact factor: 4.868

Review 9.  The role of cytokines in graft-versus-host reactions and disease.

Authors:  M R Jadus; H T Wepsic
Journal:  Bone Marrow Transplant       Date:  1992-07       Impact factor: 5.483

10.  Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

Authors:  P G Beatty; J A Hansen; G M Longton; E D Thomas; J E Sanders; P J Martin; S I Bearman; C Anasetti; E W Petersdorf; E M Mickelson
Journal:  Transplantation       Date:  1991-02       Impact factor: 4.939

View more
  2 in total

1.  Differential responsiveness of cord and adult blood monocytes to hepatocyte growth factor.

Authors:  Q Jiang; E Azuma; M Tanaka; M Kobayashi; M Hirayama; T Kumamoto; S Iwamoto; H Yamamoto; K Nakashima; M Sakurai; Y Komada
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Efficacy of azithromycin in preventing lethal graft-versus-host disease.

Authors:  S Iwamoto; E Azuma; T Kumamoto; M Hirayama; T Yoshida; M Ito; K Amano; M Ido; Y Komada
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.